# EDGAR Filing Document

**Accession Number:** 0000849869
**File Stem:** 0001628280-25-038677
**Filing Date:** 2025-8
**Character Count:** 120242
**Document Hash:** a107951b1683ae260b6070b8a0d60d07
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-038677.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001628280-25-038677

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 66

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250807

**DATE AS OF CHANGE**: 20250807

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SILGAN HOLDINGS INC
- **CENTRAL INDEX KEY:** 0000849869
- **STANDARD INDUSTRIAL CLASSIFICATION:** METAL CANS [3411]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 061269834
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41459
- **FILM NUMBER:** 251192437

**BUSINESS ADDRESS:**
- **STREET 1:** 601 MERRITT 7
- **CITY:** NORWALK
- **STATE:** CT
- **ZIP:** 06851
- **BUSINESS PHONE:** 2039757110

**MAIL ADDRESS:**
- **STREET 1:** 601 MERRITT 7
- **STREET 2:** FLOOR 1
- **CITY:** NORWALK
- **STATE:** CT
- **ZIP:** 06851

?xml version='1.0' encoding='ASCII'? slgn-20250630

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

**FORM 10-Q** 

(Mark One)

 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2025

OR

 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission file number 001-41459

**SILGAN HOLDINGS INC.** 

(Exact name of Registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Delaware | Delaware | 06-1269834 |
| (State or other jurisdiction | (State or other jurisdiction | (I.R.S. Employer |
| of incorporation or organization) | of incorporation or organization) | Identification No.) |
| 601 Merritt 7 | 601 Merritt 7 | |
| Norwalk, | Connecticut | 06851 |
| (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

(203) 975-7110

(Registrant's telephone number, including area code)

(4 Landmark Square, Stamford, CT 06901)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | SLGN | New York Stock Exchange |

---

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Smaller reporting company | ☐ |
| | | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of July 31, 2025, the number of shares outstanding of the Registrant's common stock was 106,993,180.

------

---

| | |
|:---|:---|
| SILGAN HOLDINGS INC. | SILGAN HOLDINGS INC. |
| **TABLE OF CONTENTS** | **TABLE OF CONTENTS** |
| | <u>Page No.</u> |
| <u>[Part I. Financial Information](#i28c93f13e2b2452894a22a4614c161c3_10)</u> | <u>[3](#i28c93f13e2b2452894a22a4614c161c3_10)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements](#i28c93f13e2b2452894a22a4614c161c3_13)</u> | <u>[3](#i28c93f13e2b2452894a22a4614c161c3_13)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Balance Sheets at](#i28c93f13e2b2452894a22a4614c161c3_16)[June](#i28c93f13e2b2452894a22a4614c161c3_16)[3](#i28c93f13e2b2452894a22a4614c161c3_16)[0](#i28c93f13e2b2452894a22a4614c161c3_16)[, 2025 and 2024 and December 31, 2024](#i28c93f13e2b2452894a22a4614c161c3_16)</u> | <u>[3](#i28c93f13e2b2452894a22a4614c161c3_16)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Income for the three](#i28c93f13e2b2452894a22a4614c161c3_19)[and six](#i28c93f13e2b2452894a22a4614c161c3_19)[months ended](#i28c93f13e2b2452894a22a4614c161c3_19)[June](#i28c93f13e2b2452894a22a4614c161c3_19)[3](#i28c93f13e2b2452894a22a4614c161c3_19)[0](#i28c93f13e2b2452894a22a4614c161c3_19)[, 2025 and 2024](#i28c93f13e2b2452894a22a4614c161c3_19)</u> | <u>[4](#i28c93f13e2b2452894a22a4614c161c3_19)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Comprehensive Income for the three](#i28c93f13e2b2452894a22a4614c161c3_22)[and six](#i28c93f13e2b2452894a22a4614c161c3_22)[months ended](#i28c93f13e2b2452894a22a4614c161c3_22)[June](#i28c93f13e2b2452894a22a4614c161c3_22)[3](#i28c93f13e2b2452894a22a4614c161c3_22)[0](#i28c93f13e2b2452894a22a4614c161c3_22)[, 2025 and 2024](#i28c93f13e2b2452894a22a4614c161c3_22)</u> | <u>[5](#i28c93f13e2b2452894a22a4614c161c3_22)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Cash Flows for the](#i28c93f13e2b2452894a22a4614c161c3_25)[six](#i28c93f13e2b2452894a22a4614c161c3_25)[months ended](#i28c93f13e2b2452894a22a4614c161c3_25)[June](#i28c93f13e2b2452894a22a4614c161c3_25)[3](#i28c93f13e2b2452894a22a4614c161c3_25)[0](#i28c93f13e2b2452894a22a4614c161c3_25)[, 2025 and 2024](#i28c93f13e2b2452894a22a4614c161c3_25)</u> | <u>[6](#i28c93f13e2b2452894a22a4614c161c3_25)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Stockholders' Equity for the three](#i28c93f13e2b2452894a22a4614c161c3_28)[and six](#i28c93f13e2b2452894a22a4614c161c3_28)[months ended](#i28c93f13e2b2452894a22a4614c161c3_28)[June](#i28c93f13e2b2452894a22a4614c161c3_28)[3](#i28c93f13e2b2452894a22a4614c161c3_28)[0](#i28c93f13e2b2452894a22a4614c161c3_28)[, 2025 and 2024](#i28c93f13e2b2452894a22a4614c161c3_28)</u> | <u>[7](#i28c93f13e2b2452894a22a4614c161c3_28)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Condensed Consolidated Financial Statements](#i28c93f13e2b2452894a22a4614c161c3_31)</u> | <u>[8](#i28c93f13e2b2452894a22a4614c161c3_31)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 2.&nbsp;&nbsp;&nbsp;&nbsp;Management's Discussion and Analysis of Financial Condition and Results of Operations](#i28c93f13e2b2452894a22a4614c161c3_82)</u> | <u>[18](#i28c93f13e2b2452894a22a4614c161c3_82)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 3.&nbsp;&nbsp;&nbsp;&nbsp;Quantitative and Qualitative Disclosures About Market Risk](#i28c93f13e2b2452894a22a4614c161c3_97)</u> | <u>[28](#i28c93f13e2b2452894a22a4614c161c3_97)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Controls and Procedures](#i28c93f13e2b2452894a22a4614c161c3_100)</u> | <u>[28](#i28c93f13e2b2452894a22a4614c161c3_100)</u> |
| <u>[Part II. Other Information](#i28c93f13e2b2452894a22a4614c161c3_103)</u> | <u>[29](#i28c93f13e2b2452894a22a4614c161c3_103)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 5.&nbsp;&nbsp;&nbsp;&nbsp;Other Information](#i28c93f13e2b2452894a22a4614c161c3_106)</u> | <u>[29](#i28c93f13e2b2452894a22a4614c161c3_106)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 6.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits](#i28c93f13e2b2452894a22a4614c161c3_109)</u> | <u>[29](#i28c93f13e2b2452894a22a4614c161c3_109)</u> |
| <u>[Signatures](#i28c93f13e2b2452894a22a4614c161c3_112)</u> | <u>[30](#i28c93f13e2b2452894a22a4614c161c3_112)</u> |

---

------

Part I. Financial Information

Item 1. Financial Statements

**SILGAN HOLDINGS INC.** 

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(Dollars in thousands)

---

| | | | |
|:---|:---|:---|:---|
| | June 30, 2025 | June 30, 2024 | Dec. 31, 2024 |
| | (unaudited) | (unaudited) | |
| **Assets** |  |  |  |
| Current assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $317462 | $302795 | $822854 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable, net | 1242066 | 1056785 | 594279 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 1258511 | 1005589 | 928056 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 190805 | 173464 | 177494 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 3008844 | 2538633 | 2522683 |
| Property, plant and equipment, net | 2382104 | 1933591 | 2282903 |
| Goodwill | 2484557 | 1987284 | 2316031 |
| Other intangible assets, net | 906743 | 685043 | 869468 |
| Other assets, net | 628145 | 548686 | 593583 |
|  | $9410393 | $7693237 | $8584668 |
| **Liabilities and Stockholders' Equity** |  |  |  |
| Current liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revolving loans and current portion of long-term debt | $1937384 | $1398246 | $716932 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable | 757494 | 658118 | 1111607 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued payroll and related costs | 122238 | 100663 | 108834 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 317421 | 238970 | 310159 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 3134537 | 2395997 | 2247532 |
| Long-term debt | 3114693 | 2530718 | 3419921 |
| Deferred income taxes | 478891 | 425151 | 505616 |
| Other liabilities | 460054 | 407681 | 422018 |
| Stockholders' equity: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock | 1751 | 1751 | 1751 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | 374582 | 360344 | 367871 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 3516444 | 3298525 | 3402667 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (235379) | (297530) | (353357) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock | (1435180) | (1429400) | (1429351) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 2222218 | 1933690 | 1989581 |
|  | $9410393 | $7693237 | $8584668 |

---

See accompanying notes.

------

**SILGAN HOLDINGS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

For the three and six months ended June 30, 2025 and 2024

(Dollars and shares in thousands, except per share amounts)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| Net sales | $1539161 | $1381365 | $3005822 | $2698403 |
| Cost of goods sold | 1240070 | 1125361 | 2436328 | 2218920 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 299091 | 256004 | 569494 | 479483 |
| Selling, general and administrative expenses | 121836 | 107701 | 250923 | 208177 |
| Rationalization charges | 9864 | 6859 | 20823 | 18550 |
| Other pension and postretirement (income) | (140) | (409) | (327) | (816) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before interest and income taxes | 167531 | 141853 | 298075 | 253572 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and other debt expense | 48699 | 41343 | 91627 | 79990 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | 118832 | 100510 | 206448 | 173582 |
| Provision for income taxes | 30443 | 24413 | 51259 | 42321 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before equity in earnings of affiliates | 88389 | 76097 | 155189 | 131261 |
| Equity in earnings of affiliates, net of tax | 555 |  | 1717 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $88944 | $76097 | $156906 | $131261 |
| Earnings per share:  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic net income per share | $0.83 | $0.71 | $1.47 | $1.23 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted net income per share | $0.83 | $0.71 | $1.46 | $1.23 |
| Weighted average number of shares: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 107051 | 106835 | 106984 | 106740 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive securities | 200 | 180 | 310 | 293 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 107251 | 107015 | 107294 | 107033 |

---

See accompanying notes.

------

 **SILGAN HOLDINGS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

For the three and six months ended June 30, 2025 and 2024

(Dollars in thousands)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| Net income | $88944 | $76097 | $156906 | $131261 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Changes in net prior service credit and actuarial losses | 1425 | 1411 | 2825 | 2814 |
| &nbsp;&nbsp;&nbsp; Change in fair value of derivatives | (5087) | 527 | (2016) | 2952 |
| &nbsp;&nbsp; Foreign currency translation | 71669 | (27478) | 117169 | (51935) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) | 68007 | (25540) | 117978 | (46169) |
| &nbsp;&nbsp;&nbsp;Comprehensive income | $156951 | $50557 | $274884 | $85092 |

---

See accompanying notes.

------

 **SILGAN HOLDINGS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

For the six months ended June 30, 2025 and 2024

(Dollars in thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | 2025 | 2024 |
| Cash flows provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Net income | $156906 | $131261 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash<br>&nbsp;&nbsp;&nbsp;&nbsp;provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 155335 | 131932 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount and debt issuance costs | 2617 | 2695 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rationalization charges | 20823 | 18550 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 7755 | 7948 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other changes that provided (used) cash: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable, net | (601838) | (474482) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (293758) | (74498) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable | (279697) | (227429) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (19577) | (27008) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | (53417) | (15882) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) operating activities | (904851) | (526913) |
| Cash flows provided by (used in) investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (155693) | (131442) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from asset sales | 9552 | 2984 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 297 | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) investing activities | (145844) | (128408) |
| Cash flows provided by (used in) financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings under revolving loans | 1409738 | 739385 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments under revolving loans | (51959) | (75408) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of principal amounts under finance leases | (2427) | (25267) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments of long-term debt | (706274) | (100000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in outstanding checks - principally vendors | (84971) | (160576) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends paid on common stock | (43362) | (41453) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common stock | (6873) | (7735) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 513872 | 328946 |
| Effect of exchange rate changes on cash and cash equivalents | 31431 | (13753) |
| Cash and cash equivalents: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (decrease) | (505392) | (340128) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of year | 822854 | 642923 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | $317462 | $302795 |
| Interest paid, net | $103432 | $90832 |
| Income taxes paid, net | 45259 | 43618 |

---

See accompanying notes.

------

**SILGAN HOLDINGS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

For the three and six months ended June 30, 2025 and 2024

(Dollars and shares in thousands, except per share amounts)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| Common stock - shares outstanding |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | 106993 | 106775 | 106795 | 106500 |
| &nbsp;&nbsp;&nbsp;Net issuance of treasury stock for vested &nbsp;&nbsp;&nbsp;&nbsp;restricted stock units  |  | 4 | 198 | 279 |
| &nbsp;&nbsp;&nbsp;Balance at end of period | 106993 | 106779 | 106993 | 106779 |
| Common stock - par value |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning and end of period | $1751 | $1751 | $1751 | $1751 |
| Paid-in capital |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | 371207 | 356529 | 367871 | 353848 |
| &nbsp;&nbsp;&nbsp;Stock compensation expense | 3375 | 3833 | 7755 | 7948 |
| &nbsp;&nbsp;&nbsp;Net issuance of treasury stock for vested &nbsp;&nbsp;&nbsp;&nbsp;restricted stock units |  | (18) | (1044) | (1452) |
| &nbsp;&nbsp;&nbsp;Balance at end of period | 374582 | 360344 | 374582 | 360344 |
| Retained earnings |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | 3448952 | 3242914 | 3402667 | 3208237 |
| &nbsp;&nbsp;&nbsp;Net income | 88944 | 76097 | 156906 | 131261 |
| &nbsp;&nbsp;&nbsp;Dividends declared on common stock | (21452) | (20486) | (43129) | (40973) |
| &nbsp;&nbsp;&nbsp;Balance at end of period | 3516444 | 3298525 | 3516444 | 3298525 |
| Accumulated other comprehensive loss |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | (303386) | (271990) | (353357) | (251361) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) | 68007 | (25540) | 117978 | (46169) |
| &nbsp;&nbsp;&nbsp;Balance at end of period | (235379) | (297530) | (235379) | (297530) |
| Treasury stock |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | (1435180) | (1429358) | (1429351) | (1423117) |
| &nbsp;&nbsp;&nbsp;Net issuance of treasury stock for vested &nbsp;&nbsp;&nbsp;&nbsp;restricted stock units |  | (42) | (5829) | (6283) |
| &nbsp;&nbsp;&nbsp;Balance at end of period | (1435180) | (1429400) | (1435180) | (1429400) |
| Total stockholders' equity | $2222218 | $1933690 | $2222218 | $1933690 |
| Dividends declared on common stock per share | $0.20 | $0.19 | $0.40 | $0.38 |

---

See accompanying notes.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

**Note 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Significant Accounting Policies**

**Basis of Presentation.** The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year.

The Condensed Consolidated Balance Sheet at December 31, 2024 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Note 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Revenue**

The following tables present our revenues disaggregated by reportable segment and geography as they best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues by segment were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Dispensing and Specialty Closures | $702187 | $565377 | $1373290 | $1101297 |
| Metal Containers | 676056 | 650796 | 1304483 | 1267925 |
| Custom Containers | 160918 | 165192 | 328049 | 329181 |
|  | $1539161 | $1381365 | $3005822 | $2698403 |

---

Revenues by geography were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| North America | $1041051 | $1034401 | $2058621 | $2016364 |
| Europe and other | 498110 | 346964 | 947201 | 682039 |
|  | $1539161 | $1381365 | $3005822 | $2698403 |

---

Our contract assets primarily consist of unbilled accounts receivable related to over time revenue recognition and were $121.7 million, $101.4 million, and $115.6 million as of June 30, 2025 and 2024 and December 31, 2024, respectively. Unbilled receivables are included in trade accounts receivable, net on our Condensed Consolidated Balance Sheets.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

**Note 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rationalization Charges** 

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Rationalization charges by segment were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Dispensing and Specialty Closures | $3275 | $3191 | $7646 | $9748 |
| Metal Containers | 5140 | 2493 | 10072 | 6077 |
| Custom Containers | 1449 | 1175 | 3105 | 2725 |
|  | $9864 | $6859 | $20823 | $18550 |

---

Activity in reserves for our rationalization plans were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Employee<br>Severance<br>and Benefits | Plant<br>Exit<br>Costs | Non-Cash<br>Asset<br>Write-Downs | Total |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Balance at December 31, 2024 | $29318 | $— | $— | $29318 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Charged to expense | 6181 | 3910 | 10732 | 20823 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Utilized and currency translation | (4126) | (3910) | (10732) | (18768) |
| Balance at June 30, 2025 | $31373 | $— | $— | $31373 |

---

Non-cash asset write-downs were the result of comparing the carrying value of certain facilities and production related equipment to their fair value using estimated future discounted cash flows, a Level 3 fair value measurement (see Note 7 for information regarding a Level 3 fair value measurement).

Rationalization reserves as of June 30, 2025 were recorded in our Condensed Consolidated Balance Sheet as accrued liabilities of $6.5 million and other liabilities of $24.9 million. Excluding the impact of our withdrawal from the Central States, Southeast and Southwest Areas Pension Plan, or the Central States Pension Plan, in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $16.1 million and $21.6 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $0.8 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $2.6 million annually through 2040.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

**Note 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accumulated Other Comprehensive Loss**

Accumulated other comprehensive loss is reported in our Condensed Consolidated Statements of Stockholders' Equity. Amounts included in accumulated other comprehensive loss, net of tax, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Unrecognized Net<br>Defined Benefit<br>Plan Costs | Change in Fair<br>Value of<br>Derivatives | Foreign<br>Currency<br>Translation | Total |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Balance at December 31, 2024 | $(129988) | $(5039) | $(218330) | $(353357) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income before reclassifications |  | (871) | 117169 | 116298 |
| &nbsp;&nbsp;&nbsp;Amounts reclassified from accumulated other&nbsp;&nbsp;&nbsp;&nbsp;comprehensive loss | 2825 | (1145) |  | 1680 |
| &nbsp;&nbsp;&nbsp; Other comprehensive income | 2825 | (2016) | 117169 | 117978 |
| Balance at June 30, 2025 | $(127163) | $(7055) | $(101161) | $(235379) |

---

The amounts reclassified to earnings from the unrecognized net defined benefit plan costs component of accumulated other comprehensive loss for the three and six months ended June 30, 2025 were net (losses) of $(1.8) million and $(3.6) million, respectively, excluding income tax benefits of $0.4 million and $0.8 million, respectively. For the three and six months ended June 30, 2025, these net (losses) consisted primarily of amortization of net actuarial (losses) of $(1.8) million and $(3.6) million, respectively. Amortization of net actuarial losses and net prior service credit was recorded in other pension and postretirement income in our Condensed Consolidated Statements of Income. See Note 10 for further information.

The amounts reclassified to earnings from the change in fair value of derivatives component of accumulated other comprehensive loss for the three and six months ended June 30, 2025 were not significant.

Other comprehensive income before reclassifications related to foreign currency translation for the three and six months ended June 30, 2025 consisted of (i) foreign currency gains related to translation of quarter end financial statements of foreign subsidiaries utilizing a functional currency other than the U.S. dollar of $145.5 million and $225.4 million, respectively, and (ii) foreign currency (losses) related to our net investment hedges of $(96.7) million and $(141.7) million, respectively, excluding income tax benefits of $22.9 million and $33.5 million, respectively. See Note 7 for further discussion.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

**Note 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories**

Inventories consisted of the following:

---

| | | | |
|:---|:---|:---|:---|
| | June 30, 2025 | June 30, 2024 | Dec. 31, 2024 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Raw materials | $490214 | $408681 | $450389 |
| Work-in-process | 231578 | 190661 | 199030 |
| Finished goods | 788044 | 706234 | 530406 |
| Other | 17636 | 17395 | 17192 |
|  | 1527472 | 1322971 | 1197017 |
| Adjustment to value inventory at cost on the LIFO method | (268961) | (317382) | (268961) |
|  | $1258511 | $1005589 | $928056 |

---

**Note 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Long-Term Debt**

Long-term debt consisted of the following:

---

| | | | |
|:---|:---|:---|:---|
| | June 30, 2025 | June 30, 2024 | Dec. 31, 2024 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Bank debt |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bank revolving loans | $1361887 | $665000 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S. term loans | 850000 | 850000 | 850000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Euro term loans | 1056421 |  | 931950 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other foreign bank revolving and term loans | 67224 | 54277 | 35725 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total bank debt | 3335532 | 1569277 | 1817675 |
| 3¼% Senior Notes |  | 696605 | 673075 |
| 4⅛% Senior Notes | 600000 | 600000 | 600000 |
| 2¼% Senior Notes | 586900 | 535850 | 517750 |
| 1.4% Senior Secured Notes | 500000 | 500000 | 500000 |
| Finance leases | 40943 | 38134 | 41673 |
| Total debt - principal | 5063375 | 3939866 | 4150173 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less unamortized debt issuance costs and debt discount | 11298 | 10902 | 13320 |
| Total debt | 5052077 | 3928964 | 4136853 |
| &nbsp;&nbsp;&nbsp;Less current portion | 1937384 | 1398246 | 716932 |
|  | $3114693 | $2530718 | $3419921 |

---

At June 30, 2025, the current portion of long-term debt consisted of $640.0 million of U.S. revolving loans, $721.9 million of Euro revolving loans, $8.5 million of U.S. term loans and $10.6 million of Euro term loans under our amended and restated senior secured credit facility, as amended, or the Credit Agreement, $500.0 million of our 1.4% Senior Secured Notes, $52.3 million of other foreign bank revolving and term loans and $4.1 million of finance leases.

On March 15, 2025, we repaid all €650.0 million aggregate principal amount of our outstanding 3¼% Senior Notes due 2025, or the 3¼% Notes, at 100 percent of their principal amount plus accrued and unpaid interest to the repayment date. We funded this repayment with Euro revolving loan borrowings under the Credit Agreement and cash on hand.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

**Note 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Instruments**

The financial instruments recorded in our Condensed Consolidated Balance Sheets include cash and cash equivalents, trade accounts receivable, trade accounts payable, debt obligations and swap agreements. Due to their short-term maturity, the carrying amounts of trade accounts receivable and trade accounts payable approximate their fair market values. The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at June 30, 2025:

---

| | | |
|:---|:---|:---|
| | Carrying<br>Amount | Fair<br>Value |
| | (Dollars in thousands) | (Dollars in thousands) |
| <u>Assets:</u> |  |  |
| Cash and cash equivalents | $317462 | $317462 |
| <u>Liabilities:</u> |  |  |
| Bank debt | $3335532 | $3335532 |
| 4⅛% Senior Notes | 599629 | 589818 |
| 2¼% Senior Notes | 586900 | 568677 |
| 1.4% Senior Secured Notes | 499957 | 486515 |

---

<u>Fair Value Measurements</u>

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP classifies the inputs used to measure fair value into a hierarchy consisting of three levels. Level 1 inputs represent unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 inputs represent unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability. Level 3 inputs represent unobservable inputs for the asset or liability. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

*Financial Instruments Measured at Fair Value*

The financial assets and liabilities that were measured on a recurring basis at June 30, 2025 consisted of our cash and cash equivalents and derivative instruments. We measured the fair value of cash and cash equivalents using Level 1 inputs. We measured the fair value of our derivative instruments using the income approach. The fair value of our derivative instruments reflects the estimated amounts that we would pay or receive based on the present value of the expected cash flows derived from market interest rates and prices. As such, these derivative instruments were classified within Level 2.

*Financial Instruments Not Measured at Fair Value*

Our bank debt, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were recorded at historical amounts in our Condensed Consolidated Balance Sheets, as we have not elected to measure them at fair value. We measured the fair value of our variable rate bank debt using the market approach based on Level 2 inputs. Fair values of the 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were estimated based on quoted market prices, a Level 1 input.

<u>Derivative Instruments and Hedging Activities</u>

Our derivative financial instruments were recorded in the Condensed Consolidated Balance Sheets at their fair values. Changes in fair values of derivatives are recorded in each period in earnings or comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and, if it is, the type of hedge transaction.

We utilize certain derivative financial instruments to manage a portion of our interest rate and natural gas cost exposures. We generally limit our use of derivative financial instruments to interest rate and natural gas swap agreements. We do not engage in

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

trading or other speculative uses of these financial instruments. For a financial instrument to qualify as a hedge, we must be exposed to interest rate or price risk, and the financial instrument must reduce the exposure and be designated as a hedge. Financial instruments qualifying for hedge accounting must maintain a high correlation between the hedging instrument and the item being hedged, both at inception and throughout the hedged period.

We also utilize certain internal hedging strategies to minimize our foreign currency exchange rate risk. Net investment hedges that qualify for hedge accounting result in the recognition of foreign currency gains or losses, net of tax, in accumulated other comprehensive loss.

<u>Interest Rate Swap Agreements</u>

As of June 30, 2025 and December 31, 2024, we had outstanding $300 million aggregate notional principal amount of U.S. dollar interest rate swap agreements with a weighted average fixed rate of 3.90 percent and €685.0 million aggregate notional principal amount of Euro interest rate swap agreements with a weighted average fixed rate of 2.43 percent. These agreements were entered into with financial institutions which are expected to fully perform under the terms thereof. The difference between amounts to be paid or received on our interest rate swap agreements is recorded in interest and other debt expense in our Condensed Consolidated Statements of Income and was not significant for the three and six months ended June 30, 2025. The total fair value of our interest rate swaps agreements in effect at June 30, 2025 was not significant.

<u>Natural Gas Swap Agreements</u>

We have entered into natural gas swap agreements to manage a portion of our exposure to fluctuations in natural gas prices. The difference between amounts to be paid or received on our natural gas swap agreements is recorded in cost of goods sold in our Condensed Consolidated Statements of Income and was not significant for the three and six months ended June 30, 2025. These agreements are with a financial institution which is expected to fully perform under the terms thereof. The total fair value of our natural gas swap agreements in effect at June 30, 2025 was not significant.

<u>Foreign Currency Exchange Rate Risk</u>

In an effort to minimize our foreign currency exchange rate risk, we have financed acquisitions of foreign operations primarily with borrowings denominated in Euros. In addition, where available, we have borrowed funds in local currency or implemented certain internal hedging strategies to minimize our foreign currency exchange rate risk related to foreign operations, including net investment hedges related to the Euro term loans under the Credit Agreement which are Euro denominated. Foreign currency (losses) related to our net investment hedges included in accumulated other comprehensive loss for the three and six months ended June 30, 2025 were $(96.7) million and $(141.7) million, respectively.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

**Note 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commitments and Contingencies**

We are a party to other legal proceedings, contract disputes and claims arising in the ordinary course of our business. We are not a party to, and none of our properties are subject to, any pending legal proceedings which could have a material adverse effect on our business or financial condition.

**Note 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Finance Program**

We have a supply chain finance ("SCF") program with a major global financial institution. Under this SCF program, a qualifying supplier may elect, but is not obligated, to sell its receivables from us to such financial institution. Once a qualifying supplier elects to participate in this SCF program, all of our payments to the participating supplier are paid to such financial institution in this SCF program on the invoice due date under our agreement with such supplier, regardless of whether the individual invoice was sold by the supplier to such financial institution. We may terminate our agreement with the financial institution upon at least 30 days' notice, and the financial institution may terminate our agreement upon at least 10 days' notice. Additionally, suppliers who elect to participate in this SCF program may terminate their participation upon at least 30 days' notice. The suppliers' invoices sold under this SCF program can be outstanding up to 210 days from the invoice date. Suppliers' invoices included in this SCF program were $248.4 million, $251.0 million and $303.7 million at June 30, 2025 and 2024 and December 31, 2024, respectively, and were included in accounts payable in our Condensed Consolidated Balance Sheets.

**Note 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Retirement Benefits** 

The components of the net periodic pension benefit cost were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Service cost | $1968 | $2164 | $3912 | $4329 |
| Interest cost | 8177 | 8408 | 16296 | 16821 |
| Expected return on plan assets | (10256) | (10771) | (20513) | (21542) |
| Amortization of prior service cost | 5 | 23 | 13 | 46 |
| Amortization of actuarial losses | 1883 | 1853 | 3776 | 3705 |
| Net periodic benefit cost | $1777 | $1677 | $3484 | $3359 |

---

The components of the net periodic other postretirement benefit cost were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Service cost | $6 | $7 | $10 | $14 |
| Interest cost | 151 | 167 | 302 | 332 |
| Amortization of prior service credit | (14) | (5) | (29) | (10) |
| Amortization of actuarial gains | (86) | (84) | (172) | (168) |
| Net periodic benefit cost | $57 | $85 | $111 | $168 |

---

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

**Note 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income Taxes**

Silgan and its subsidiaries file U.S. Federal income tax returns, as well as income tax returns in various states and foreign jurisdictions. The Internal Revenue Service, or IRS, has completed its review of the 2023 tax year with no change to our filed federal income tax return. We have been accepted into the Compliance Assurance Program for the 2024 and 2025 tax years which provides for the review by the IRS of tax matters relating to our tax return prior to filing.

**Note 12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treasury Stock**

On March 4, 2022, our Board of Directors authorized the repurchase by us of up to an aggregate of $300.0 million of our common stock by various means from time to time through and including December 31, 2026. We did not repurchase any shares of our common stock pursuant to this authorization during the six months ended June 30, 2025. At June 30, 2025, we had approximately $93.3 million remaining under this authorization for the repurchase of our common stock.

During the first six months of 2025, we issued 325,808 treasury shares which had an average cost of $3.20 per share for restricted stock units that vested during the period that had been previously issued under our stock-based compensation plans. In accordance with the applicable agreements for such restricted stock units, we repurchased 127,278 shares of our common stock at an average cost of $54.00 to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units.

We account for treasury shares using the first-in, first-out (FIFO) cost method. As of June 30, 2025, 68,119,316 shares of our common stock were held in treasury.

**Note 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stock-Based Compensation**

We currently have one stock-based compensation plan in effect under which we have issued restricted stock units to our officers, other key employees and outside directors. During the first six months of 2025, 727,234 restricted stock units were granted to certain of our officers, other key employees and outside directors. The fair value of these restricted stock units at the grant date was $39.3 million, which is being amortized ratably over the respective vesting period from the grant date.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

**Note 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Segment Information**

Our chief operating decision maker, who is our Chief Executive Officer and President, evaluates performance of our business segments and allocates resources based on the adjusted EBIT of our business segments. Adjusted EBIT is not a defined term under GAAP. We define adjusted EBIT as income before interest and income taxes excluding acquired intangible asset amortization expense, other pension (income) expense for U.S. pension plans, rationalization charges and costs attributed to announced acquisitions and including, as applicable, equity in earnings of affiliates, net of tax. Adjusted EBIT should not be considered in isolation or as a substitute for income before interest and income taxes or any other financial data prepared in accordance with GAAP and may not be comparable to calculations of similarly titled measures by other companies.

Reportable segment information was as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Dispensing and Specialty Closures | Metal<br>Containers | Custom<br>Containers | Corporate | Total |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| <u>Three Months Ended June 30, 2025</u> |  |  |  |  |  |
| Net sales | $702187 | $676056 | $160918 | $— | $1539161 |
| Segment expenses and other <sup>(a)</sup> | 594817 | 605285 | 135989 | 10654 | 1346745 |
| Equity in earnings of affiliates, net of tax | 555 |  |  |  | 555 |
| Adjusted EBIT | 107925 | 70771 | 24929 | (10654) | 192971 |
| Depreciation | 37633 | 13607 | 8684 | 102 | 60026 |
| Capital expenditures | 48707 | 17728 | 5826 | 508 | 72769 |
| <u>Three Months Ended June 30, 2024</u> |  |  |  |  |  |
| Net sales | $565377 | $650796 | $165192 | $— | $1381365 |
| Segment expenses and other <sup>(a)</sup> | 472670 | 592283 | 142647 | 8401 | 1216001 |
| Adjusted EBIT | 92707 | 58513 | 22545 | (8401) | 165364 |
| Depreciation | 25384 | 18892 | 8823 | 47 | 53146 |
| Capital expenditures | 26149 | 22645 | 7386 | 4 | 56184 |
| <u>Six Months Ended June 30, 2025</u> |  |  |  |  |  |
| Net sales | $1373290 | $1304483 | $328049 | $— | $3005822 |
| Segment expenses and other <sup>(a)</sup> | 1167879 | 1184156 | 278536 | 25727 | 2656298 |
| Equity in earnings of affiliates, net of tax | 1717 |  |  |  | 1717 |
| Adjusted EBIT | 207128 | 120327 | 49513 | (25727) | 351241 |
| Depreciation | 73488 | 32892 | 17448 | 148 | 123976 |
| Segment assets | 5846884 | 2706408 | 780467 | 39861 | 9373620 |
| Capital expenditures | 92141 | 48971 | 13665 | 916 | 155693 |
| <u>Six Months Ended June 30, 2024</u> |  |  |  |  |  |
| Net sales | $1101297 | $1267925 | $329181 | $— | $2698403 |
| Segment expenses and other <sup>(a)</sup> | 930740 | 1164458 | 286468 | 15893 | 2397559 |
| Adjusted EBIT | 170557 | 103467 | 42713 | (15893) | 300844 |
| Depreciation | 50535 | 37805 | 17887 | 68 | 106295 |
| Segment assets | 4389613 | 2398402 | 817205 | 38219 | 7643439 |
| Capital expenditures | 56014 | 59869 | 15541 | 18 | 131442 |

---

(a)&nbsp;&nbsp;&nbsp;&nbsp;Segment expenses and other includes cost of goods sold, selling, general and administrative expenses, and other pension and postretirement (income) expense and excludes acquired intangible asset amortization expense, other pension (income) expense only for U.S. pension plans, and costs attributed to announced acquisitions.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at June 30, 2025 and 2024 and for the

three and six months then ended is unaudited)

Total adjusted EBIT is reconciled to income before income taxes as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Total adjusted EBIT | $192971 | $165364 | $351241 | $300844 |
| Less: |  |  |  |  |
| Acquired intangible asset amortization expense | 15946 | 12356 | 31359 | 25637 |
| Other pension (income) for U.S. pension plans | (925) | (1211) | (1850) | (2422) |
| Equity in earnings of affiliates, net of tax | 555 |  | 1717 |  |
| Rationalization charges | 9864 | 6859 | 20823 | 18550 |
| Costs attributed to announced acquisitions |  | 5507 | 1117 | 5507 |
| &nbsp;&nbsp;Income before interest and income taxes | 167531 | 141853 | 298075 | 253572 |
| Interest and other debt expense | 48699 | 41343 | 91627 | 79990 |
| &nbsp;&nbsp;Income before income taxes | $118832 | $100510 | $206448 | $173582 |

---

Net sales and adjusted EBIT of our metal containers segment and of part of our dispensing and specialty closures segment are dependent, in part, upon the vegetable and fruit harvests in the United States and, to a lesser extent, in a variety of national growing regions in Europe. The size and quality of these harvests varies from year to year, depending in large part upon the weather conditions in applicable regions. Because of the seasonality of the harvests, we have historically experienced higher unit sales volume in the third quarter of our fiscal year and generated a disproportionate amount of our annual adjusted EBIT during that quarter.

------

Item 2.

**MANAGEMENT'S DISCUSSION AND ANALYSIS OF**

**<u>FINANCIAL CONDITION AND RESULTS OF OPERATIONS</u>**

Statements included in "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in this Quarterly Report on Form 10-Q that are not historical facts are "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Securities Exchange Act of 1934, as amended. Such forward-looking statements are made based upon management's expectations and beliefs concerning future events impacting us and therefore involve a number of uncertainties and risks, including, but not limited to, those described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in our other filings with the Securities and Exchange Commission. As a result, the actual results of our operations or our financial condition could differ materially from those expressed or implied in these forward-looking statements.

***General***

We are a leading manufacturer and supplier of sustainable rigid packaging solutions for the world's essential consumer goods products. We currently produce dispensing and specialty closures for the fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden markets; steel and aluminum containers for pet and human food and general line products; and custom designed plastic containers for the pet and human food, consumer health and pharmaceutical, personal care, home care, lawn and garden and automotive markets. We are a leading worldwide manufacturer of dispensing and specialty closures, a leading manufacturer of metal containers in North America and Europe, and a leading manufacturer of custom containers in North America for a variety of markets.

Our objective is to increase shareholder value by efficiently deploying capital and management resources to grow our business, reduce operating costs and build sustainable competitive positions, or franchises, and to complete acquisitions that generate attractive cash returns. We have grown our net sales and income from operations largely through acquisitions but also through internal growth, and we continue to evaluate acquisition opportunities in the consumer goods packaging market. If acquisition opportunities are not identified over a longer period of time, we may use our cash flow to repay debt, repurchase shares of our common stock or increase dividends to our stockholders or for other permitted purposes.

In October 2024, we acquired Weener Plastics Holding B.V., or Weener Packaging. Weener Packaging's results of operations are included in our dispensing and specialty closures segment.

------

**RESULTS OF OPERATIONS**

The following table sets forth certain unaudited income statement data expressed as a percentage of net sales for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| Net sales |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Dispensing and Specialty Closures | 45.6% | 40.9% | 45.7% | 40.8% |
| &nbsp;&nbsp;&nbsp;Metal Containers | 43.9 | 47.1 | 43.4 | 47.0 |
| &nbsp;&nbsp;&nbsp;Custom Containers | 10.5 | 12.0 | 10.9 | 12.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | 100.0 | 100.0 | 100.0 | 100.0 |
| Cost of goods sold | 80.6 | 81.5 | 81.1 | 82.2 |
| &nbsp;&nbsp;Gross profit | 19.4 | 18.5 | 18.9 | 17.8 |
| Selling, general and administrative expenses | 7.9 | 7.8 | 8.3 | 7.7 |
| Rationalization charges | 0.6 | 0.4 | 0.7 | 0.7 |
| Other pension and postretirement income |  |  |  |  |
| &nbsp;&nbsp;Income before interest and income taxes | 10.9 | 10.3 | 9.9 | 9.4 |
| Interest and other debt expense | 3.2 | 3.0 | 3.0 | 2.9 |
| &nbsp;&nbsp;Income before income taxes | 7.7 | 7.3 | 6.9 | 6.5 |
| Provision for income taxes | 2.0 | 1.8 | 1.7 | 1.6 |
| Income before equity in earnings of affiliates | 5.7 | 5.5 | 5.2 | 4.9 |
| Equity in earnings of affiliates, net of tax | 0.1 |  | 0.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | 5.8% | 5.5% | 5.3% | 4.9% |

---

Summary unaudited results of operations for the periods presented are provided below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (dollars in millions) | (dollars in millions) | (dollars in millions) | (dollars in millions) |
| Net sales |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Dispensing and Specialty Closures | $702.2 | $565.4 | $1373.3 | $1101.3 |
| &nbsp;&nbsp;&nbsp;Metal Containers | 676.1 | 650.8 | 1304.5 | 1267.9 |
| &nbsp;&nbsp;&nbsp;Custom Containers | 160.9 | 165.2 | 328.0 | 329.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | $1539.2 | $1381.4 | $3005.8 | $2698.4 |
| Income before interest and income taxes |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Dispensing and Specialty Closures | $89.8 | $78.9 | $169.7 | $138.7 |
| &nbsp;&nbsp;&nbsp;Metal Containers | 65.7 | 56.3 | 110.5 | 98.0 |
| &nbsp;&nbsp;&nbsp;Custom Containers | 22.6 | 20.5 | 44.7 | 38.3 |
| &nbsp;&nbsp;&nbsp;Corporate | (10.6) | (13.9) | (26.8) | (21.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | $167.5 | $141.8 | $298.1 | $253.6 |

---

***Net Sales***. In the second quarter of 2025, consolidated net sales were $1.5 billion, an increase of $157.8 million, or 11.4 percent, as compared to the second quarter of 2024 primarily due to higher net sales in the dispensing and specialty closures segment as a result of the inclusion of net sales from Weener Packaging and higher organic unit volumes of dispensing products, the pass through of higher raw material and other manufacturing costs in the metal containers segment and the impact from favorable foreign currency translation of approximately $13.0 million, partially offset by lower unit volumes of specialty

------

closures primarily for the North American beverage markets in the dispensing and specialty closures segment, lower volumes in the custom containers segment and a less favorable mix of products sold in the metal containers segment.

In the first six months of 2025, consolidated net sales were $3.0 billion, an increase of $307.4 million, or 11.4 percent, as compared to the first six months of 2024 primarily due to higher net sales in the dispensing and specialty closures segment as a result of the inclusion of net sales from Weener Packaging and higher organic unit volumes of dispensing products, the pass through of higher raw material and other manufacturing costs and higher unit volumes in the metal containers segment and the pass through of higher raw material costs in the custom containers segment. These increases were partially offset by a less favorable mix of products sold in the metal containers segment, lower unit volumes of specialty closures primarily for the North American beverage markets in the dispensing and specialty closures segment and the impact of unfavorable foreign currency translation of approximately $3.0 million.

***Gross Profit***. Gross profit margin increased 0.9 percentage points to 19.4 percent in the second quarter of 2025 as compared to the same period in 2024 and increased 1.1 percentage points to 18.9 percent in the first six months of 2025 as compared to the same periods in 2024 primarily for the reasons discussed below in "Income before Interest and Income Taxes".

***Selling, General and Administrative Expenses***. In the second quarter of 2025, selling, general and administrative expenses as a percentage of consolidated net sales increased to 7.9 percent as compared to 7.8 percent in the second quarter of 2024. For the second quarter of 2025, selling, general and administrative expenses increased $14.1 million to $121.8 million as compared to the second quarter of 2024. In the first six months of 2025, selling, general and administrative expenses as a percentage of consolidated net sales increased to 8.3 percent as compared to 7.7 percent in the first six months of 2024. In the first six months of 2025, selling, general and administrative expenses increased $42.7 million to $250.9 million as compared to the first six months of 2024. The increase in selling, general and administrative expenses for each of the second quarter and the first six months of 2025 was primarily due to the inclusion of selling, general and administrative expenses of Weener Packaging and higher expenses for corporate development activities.

***Income before Interest and Income Taxes***. In the second quarter of 2025, income before interest and income taxes increased by $25.7 million to $167.5 million as compared to $141.8 million in the second quarter of 2024, and margins increased to 10.9 percent from 10.3 percent over the same periods. The increase in income before interest and income taxes was primarily the result of the inclusion of income before interest and income taxes of Weener Packaging, improved manufacturing productivity and cost performance in the metal containers and custom containers segments and higher organic unit volumes of dispensing products in the dispensing and specialty closures segment, partially offset by a less favorable mix of products sold in the metal containers segment and a decline in unit volumes for specialty closures in the dispensing and specialty closures segment. Rationalization charges were $9.9 million and $6.9 million in the second quarters of 2025 and 2024, respectively. Costs attributed to announced acquisitions were $5.5 million in the second quarter of 2024.

In the first six months of 2025, income before interest and income taxes increased by $44.5 million to $298.1 million as compared to $253.6 million in the first six months of 2024, and margins increased to 9.9 percent from 9.4 percent over the same periods. The increase in income before interest and income taxes was primarily the result of the inclusion of income before interest and income taxes of Weener Packaging, improved manufacturing productivity and cost performance in the metal containers and custom containers segments and higher organic unit volumes of dispensing products in the dispensing and specialty closures segment, partially offset by a less favorable mix of products sold in the metal containers segment, a decline in unit volumes for specialty closures in the dispensing and specialty closures segment and the unfavorable impact of foreign currency. Rationalization charges were $20.8 million and $18.6 million in the first six months of 2025 and 2024, respectively. Costs attributed to announced acquisitions were $1.1 million and $5.5 million in the first six months of 2025 and 2024, respectively.

***Interest and Other Debt Expense****.* In the second quarter of 2025, interest and other debt expense increased $7.4 million to $48.7 million as compared to $41.3 million in the second quarter of 2024. In the first six months of 2025, interest and other debt expense increased $11.6 million to $91.6 million as compared to $80.0 million in the first six months of 2024. The increases in interest and other debt expense in both the second quarter and first six months of 2025 were primarily due to higher average borrowings during the current year period related to the Weener Packaging acquisition completed in October 2024.

***Provision for Income Taxes****.* For the second quarters of 2025 and 2024, the effective tax rates were 25.6 percent and 24.3 percent, respectively. For the first six months of 2025 and 2024, the effective tax rates were 24.8 percent and 24.4 percent, respectively. The increase in the effective tax rate in the second quarter of 2025 was primarily due to changes in the geographic mix of profit in the current year period as compared to the prior year period.

------

**Non-GAAP Measures**

Generally accepted accounting principles in the United States are commonly referred to as GAAP. A non-GAAP financial measure is generally defined as a financial measure that purports to measure financial performance, financial position or liquidity but excludes or includes amounts that could not be so adjusted in the most comparable GAAP measure. Adjusted EBIT and adjusted EBIT margin are unaudited supplemental measures of financial performance that the Company uses, which are not required by, or presented in accordance with, GAAP and therefore are non-GAAP financial measures. These non-GAAP financial measures should not be considered as alternatives to income before interest and income taxes or any other measures derived in accordance with GAAP. Such non-GAAP financial measures should not be considered in isolation or as a substitute for any financial data prepared in accordance with GAAP and may not be comparable to similarly titled measures used by other companies. The Company uses such non-GAAP financial measures because it considers them to be important and useful supplemental measures of its and its segments' financial performance which provide a more complete understanding of the Company and its segments than could be obtained absent such non-GAAP financial measures. The Company believes that it is important and useful to present these non-GAAP financial measures because they allow for a better period-over-period comparison of results by removing the impact of items that, in management's view, do not reflect the Company's or its segments' core operating performance. Management uses these non-GAAP financial measures to review and analyze the operating performance of the Company and its segments. Investors and others are urged to review and consider carefully the adjustments made by management to the most comparable GAAP financial measure to arrive at these non-GAAP financial measures.

Adjusted EBIT, a non-GAAP financial measure, means income before interest and income taxes excluding, as applicable, acquired intangible asset amortization expense, other pension (income) expense for U.S. pension plans, rationalization charges and costs attributed to announced acquisitions and including, as applicable, equity in earnings of affiliates, net of tax. Adjusted EBIT margin, a non-GAAP financial measure, means adjusted EBIT divided by segment net sales.

Acquired intangible asset amortization expense is a non-cash expense related to acquired operations that management believes is not indicative of the on-going performance of the acquired operations. Since the Company's U.S. pension plans are significantly over funded and have no required cash contributions for the foreseeable future based on current regulations, management views other pension (income) expense from the Company's U.S. pension plans, which excludes service costs, as not reflective of the operational performance of the Company or its segments. While rationalization costs are incurred on a regular basis, management views these costs more as an investment to generate savings rather than period costs. Costs attributed to announced acquisitions consist of third party fees and expenses that are viewed by management as part of the acquisition and not indicative of the on-going cost structure of the Company. The Company's management views the operating performance of its affiliates which are joint ventures as part of the Company's operating performance and therefore believes that the Company's share of the net operating results of its affiliates which are joint ventures should be included in the Company's adjusted EBIT.

------

A reconciliation of such non-GAAP financial measures for the periods presented is provided below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in millions) | (Dollars in millions) | (Dollars in millions) | (Dollars in millions) |
| **<u>Dispensing and Specialty Closures</u>** |  |  |  |  |
| Income before interest and income taxes (EBIT) | $89.8 | $78.9 | $169.7 | $138.7 |
| Acquired intangible asset amortization expense | 14.4 | 10.9 | 28.4 | 22.6 |
| Other pension (income) for U.S. pension plans | (0.2) | (0.3) | (0.3) | (0.5) |
| Equity in earnings of affiliates, net of tax | 0.6 |  | 1.7 |  |
| Rationalization charges | 3.3 | 3.2 | 7.6 | 9.7 |
| &nbsp;&nbsp;&nbsp;Adjusted EBIT | $107.9 | $92.7 | $207.1 | $170.5 |
| **<u>Metal Containers</u>** |  |  |  |  |
| Income before interest and income taxes (EBIT) | $65.7 | $56.3 | $110.5 | $98.0 |
| Acquired intangible asset amortization expense | 0.4 | 0.3 | 0.7 | 0.7 |
| Other pension (income) for U.S. pension plans | (0.4) | (0.6) | (1.0) | (1.3) |
| Rationalization charges | 5.1 | 2.5 | 10.1 | 6.1 |
| &nbsp;&nbsp;&nbsp;Adjusted EBIT | $70.8 | $58.5 | $120.3 | $103.5 |
| **<u>Custom Containers</u>** |  |  |  |  |
| Income before interest and income taxes (EBIT) | $22.6 | $20.5 | $44.7 | $38.3 |
| Acquired intangible asset amortization expense | 1.1 | 1.1 | 2.2 | 2.3 |
| Other pension (income) for U.S. pension plans | (0.3) | (0.3) | (0.5) | (0.6) |
| Rationalization charges | 1.5 | 1.2 | 3.1 | 2.7 |
| &nbsp;&nbsp;&nbsp;Adjusted EBIT | $24.9 | $22.5 | $49.5 | $42.7 |
| **<u>Corporate</u>** |  |  |  |  |
| Loss before interest and income taxes (EBIT) | $(10.6) | $(13.9) | $(26.8) | $(21.4) |
| Costs attributed to announced acquisitions |  | 5.5 | 1.1 | 5.5 |
| &nbsp;&nbsp;&nbsp;Adjusted EBIT | $(10.6) | $(8.4) | $(25.7) | $(15.9) |
| Total adjusted EBIT | $193.0 | $165.3 | $351.2 | $300.8 |

---

------

**Dispensing and Specialty Closures Segment**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in millions) | (Dollars in millions) | (Dollars in millions) | (Dollars in millions) |
| Net sales | $702.2 | $565.4 | $1373.3 | $1101.3 |
| Income before interest and income taxes (EBIT) | 89.8 | 78.9 | 169.7 | 138.7 |
| Income before interest and income taxes margin (EBIT margin) | 12.8% | 14.0% | 12.4% | 12.6% |
| Adjusted EBIT | $107.9 | $92.7 | $207.1 | $170.5 |
| Adjusted EBIT margin | 15.4% | 16.4% | 15.1% | 15.5% |

---

In the second quarter of 2025, net sales for the dispensing and specialty closures segment increased $136.8 million, or 24.2 percent, as compared to the second quarter of 2024. This increase was primarily the result of higher net sales of $143.6 million due to the inclusion of net sales from Weener Packaging and higher organic unit volumes of dispensing products and the impact of favorable foreign currency translation of approximately $8.0 million, partially offset by lower unit volumes of specialty closures of approximately three percent primarily as a result of a decline in volumes for the North American beverage markets due to cool and wet weather conditions and lower than anticipated promotional activity.

In the first six months of 2025, net sales for the dispensing and specialty closures segment increased $272.0 million, or 24.7 percent, as compared to the first six months of 2024. This increase was primarily the result of higher net sales of $287.0 million due to the inclusion of net sales from Weener Packaging and higher organic unit volumes of dispensing products, partially offset by the impact of unfavorable foreign currency translation of approximately $4.0 million and lower unit volumes of specialty closures of approximately two percent primarily as a result of a decline in volumes for the North American beverage markets due to cool and wet weather conditions and lower than anticipated promotional activity.

In the second quarter of 2025, adjusted EBIT of the dispensing and specialty closures segment increased $15.2 million as compared to the second quarter of 2024, while adjusted EBIT margin decreased to 15.4 percent from 16.4 percent over the same periods. The increase in adjusted EBIT was primarily due to the inclusion of adjusted EBIT from Weener Packaging and higher organic unit volumes for dispensing products, partially offset by a decline in unit volumes for specialty closures.

In the first six months of 2025, adjusted EBIT of the dispensing and specialty closures segment increased $36.6 million as compared to the first six months of 2024, while adjusted EBIT margin decreased to 15.1 percent from 15.5 percent over the same periods. The increase in adjusted EBIT was primarily due to the inclusion of adjusted EBIT from Weener Packaging and higher organic unit volumes for dispensing products, partially offset by a decline in unit volumes for specialty closures and the unfavorable impact of foreign currency.

------

**Metal Containers Segment**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in millions) | (Dollars in millions) | (Dollars in millions) | (Dollars in millions) |
| Net sales | $676.1 | $650.8 | $1304.5 | $1267.9 |
| Income before interest and income taxes (EBIT) | 65.7 | 56.3 | 110.5 | 98.0 |
| Income before interest and income taxes margin (EBIT margin) | 9.7% | 8.7% | 8.5% | 7.7% |
| Adjusted EBIT | $70.8 | $58.5 | $120.3 | $103.5 |
| Adjusted EBIT margin | 10.5% | 9.0% | 9.2% | 8.2% |

---

In the second quarter of 2025, net sales for the metal containers segment increased $25.3 million, or 3.9 percent, as compared to the second quarter of 2024. This increase was primarily the result of the pass through of higher raw material and other manufacturing costs and the impact of favorable foreign currency translation of approximately $5.0 million, partially offset by a less favorable mix of products sold. Unit volumes for the metal containers segment were comparable to the prior year period with higher volumes for pet food markets offset by lower volumes for soup markets.

In the first six months of 2025, net sales for the metal containers segment increased $36.6 million, or 2.9 percent, as compared to the first six months of 2024. This increase was primarily the result of the pass through of higher raw material and other manufacturing costs, higher unit volumes of approximately two percent and the impact of favorable foreign currency translation of approximately $3.0 million, partially offset by a less favorable mix of products sold. The increase in unit volumes was primarily due to higher volumes for pet food markets.

In the second quarter of 2025, adjusted EBIT of the metal containers segment increased $12.3 million as compared to the second quarter of 2024, and adjusted EBIT margin increased to 10.5 percent from 9.0 percent for the same periods. The increase in adjusted EBIT was primarily due to improved manufacturing productivity and cost performance due in part to lower production in the prior year period associated with a customer that reduced its fruit and vegetable pack plans, partially offset by a less favorable mix of products sold due to higher unit volumes of smaller cans for pet food markets.

In the first six months of 2025, adjusted EBIT of the metal containers segment increased $16.8 million as compared to the first six months of 2024, and adjusted EBIT margin increased to 9.2 percent from 8.2 percent for the same periods. The increase in adjusted EBIT was primarily due to improved manufacturing productivity and cost performance due in part to lower production in the prior year period associated with a customer that reduced its fruit and vegetable pack plans, partially offset by a less favorable mix of products sold due to higher unit volumes of smaller cans for pet food markets.

------

**Custom Containers Segment**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
| | June 30, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 |
| | (Dollars in millions) | (Dollars in millions) | (Dollars in millions) | (Dollars in millions) |
| Net sales | $160.9 | $165.2 | $328.0 | $329.2 |
| Income before interest and income taxes (EBIT) | 22.6 | 20.5 | 44.7 | 38.3 |
| Income before interest and income taxes margin (EBIT margin) | 14.0% | 12.4% | 13.6% | 11.6% |
| Adjusted EBIT | $24.9 | $22.5 | $49.5 | $42.7 |
| Adjusted EBIT margin | 15.5% | 13.6% | 15.1% | 13.0% |

---

In the second quarter of 2025, net sales for the custom containers segment decreased $4.3 million, or 2.6 percent, as compared to the second quarter of 2024. This decrease was principally due to lower volumes of approximately two percent due primarily to the exit of lower margin business as a result of footprint optimization plans.

In the first six months of 2025, net sales for the custom containers segment decreased $1.2 million, or 0.4 percent, as compared to the first six months of 2024. This decrease was principally due to unfavorable foreign currency translation of approximately $2.0 million, partially offset by the pass through of higher raw material costs.

In the second quarter of 2025, adjusted EBIT of the custom containers segment increased $2.4 million as compared to the second quarter of 2024, and adjusted EBIT margin increased to 15.5 percent from 13.6 percent over the same periods. The increase in adjusted EBIT was primarily attributable to improved manufacturing productivity and cost performance.

In the first six months of 2025, adjusted EBIT of the custom containers segment increased $6.8 million as compared to the first six months of 2024, and adjusted EBIT margin increased to 15.1 percent from 13.0 percent over the same periods. The increase in adjusted EBIT was primarily attributable to improved manufacturing productivity and cost performance.

**CAPITAL RESOURCES AND LIQUIDITY**

Our principal sources of liquidity have been net cash from operating activities and borrowings under our debt instruments, including our senior secured credit facility. Our liquidity requirements arise from our obligations under the indebtedness incurred in connection with our acquisitions and the refinancing of that indebtedness, capital investment in new and existing equipment, the funding of our seasonal working capital needs and other general corporate uses.

On March 15, 2025, we repaid all €650.0 million aggregate principal amount of our outstanding 3¼% Notes at 100 percent of their principal amount plus accrued and unpaid interest to the repayment date. We funded this repayment with Euro revolving loan borrowings under the Credit Agreement and cash on hand.

For the six months ended June 30, 2025, we used net borrowings of revolving loans of $1.4 billion, cash and cash equivalents of $505.4 million and the positive effect of exchange rate changes on cash and cash equivalents of $31.4 million to fund cash used in operations of $904.9 million, the repayment of long-term debt of $706.3 million, net capital expenditures and other investing activities of $145.8 million, decreases in outstanding checks of $85.0 million, dividends paid on our common stock of $43.4 million, repurchases of our common stock of $6.9 million and the repayment of principal amounts under finance leases of $2.4 million.

For the six months ended June 30, 2024, we used net borrowings of revolving loans of an aggregate of $664.0 million and cash and cash equivalents of $340.1 million to fund cash used in operations of $526.9 million, decreases in outstanding checks of $160.6 million, the repayment of long-term debt of $100.0 million, net capital expenditures and other investing activities of $128.4 million, dividends paid on our common stock of $41.5 million, the repayment of principal amounts under finance leases of $25.3 million, repurchases of our common stock of $7.7 million and the negative effect of exchange rate changes on cash and cash equivalents of $13.7 million.

------

At June 30, 2025, we had $1.4 billion of revolving loans outstanding under the Credit Agreement. After taking into account outstanding letters of credit, the available portion of revolving loans under the Credit Agreement at June 30, 2025 was $118.3 million.

Because we sell metal containers and closures used in fruit and vegetable pack processing, we have seasonal sales. As is common in the industry, we must utilize working capital to build inventory and then carry accounts receivable for some customers beyond the end of the packing season. Due to our seasonal requirements, which generally peak sometime in the summer or early fall, we may incur short-term indebtedness to finance our working capital requirements. Our peak seasonal working capital requirements have historically averaged approximately $375 million. We fund seasonal working capital requirements through revolving loans under the Credit Agreement, other foreign bank loans and cash on hand. We may use the available portion of revolving loans under the Credit Agreement, after taking into account our seasonal needs and outstanding letters of credit, for other general corporate purposes including acquisitions, capital expenditures, dividends, stock repurchases and to refinance or repurchase other debt.

We believe that cash generated from operations and funds from borrowings available under the Credit Agreement and other foreign bank loans will be sufficient to meet our expected operating needs, planned capital expenditures, debt service, tax obligations, pension benefit plan contributions, share repurchases and common stock dividends for the foreseeable future. We continue to evaluate acquisition opportunities in the consumer goods packaging market and may incur additional indebtedness, including indebtedness under the Credit Agreement, to finance any such acquisition.

We are in compliance with all financial and operating covenants contained in our financing agreements and believe that we will continue to be in compliance during 2025 with all of these covenants.

***Supply Chain Finance Program***

For our suppliers, we believe that we negotiate the best terms possible, including payment terms. In connection therewith, we initiated a SCF program with a major global financial institution. Under this SCF program, a qualifying supplier may elect, but is not obligated, to sell its receivables from us to such financial institution. A participating supplier negotiates its receivables sale arrangements directly with the financial institution under this SCF program. While we are not party to, and do not participate in the negotiation of, such arrangements, such financial institution allows a participating supplier to utilize our creditworthiness in establishing a credit spread in respect of the sale of its receivables from us as well as other applicable terms. This may provide a supplier with more favorable terms than it would be able to secure on its own. We have no economic interest in a supplier's decision to sell a receivable. Once a qualifying supplier elects to participate in this SCF program and reaches an agreement with the financial institution, the supplier independently elects which individual invoices to us that they sell to the financial institution. All of our payments to a participating supplier are paid to the financial institution on the invoice due date under our agreement with such supplier, regardless of whether the individual invoice was sold by the supplier to the financial institution. The financial institution then pays the supplier on the invoice due date under our agreement with such supplier for any invoices not previously sold by the supplier to the financial institution. Amounts due to a supplier that elects to participate in this SCF program are included in accounts payable in our Condensed Consolidated Balance Sheet, and the associated payments are reflected in net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows. Separate from this SCF program, we and suppliers who participate in this SCF program generally maintain the contractual right to require the other party to negotiate in good faith the existing payment terms as a result of changes in market conditions, including changes in interest rates and general market liquidity, or in some cases for any reason. Outstanding trade accounts payables subject to this SCF program were approximately $248.4 million, $251.0 million and $303.7 million at June 30, 2025 and 2024 and December 31, 2024, respectively.

***Guaranteed Securities***

Each of the 4⅛% Senior Notes, the 2¼% Senior Notes and the 1.4% Senior Secured Notes were issued by Silgan and are guaranteed by our U.S. subsidiaries that also guarantee our obligations under the Credit Agreement, collectively the Obligor Group.

The following summarized financial information relates to the Obligor Group as of June 30, 2025 and December 31, 2024 and for the six months ended June 30, 2025. Intercompany transactions, equity investments and other intercompany activity within the Obligor Group have been eliminated from the summarized financial information. Investments in subsidiaries of Silgan that are not part of the Obligor Group of $2.4 billion and $2.1 billion as of June 30, 2025 and December 31, 2024, respectively, are not included in noncurrent assets in the table below.

------

---

| | | |
|:---|:---|:---|
| | June 30, 2025 | Dec. 31, 2024 |
| | (Dollars in millions) | (Dollars in millions) |
| Current assets | $1773.9 | $1464.5 |
| Noncurrent assets | 4352.2 | 4279.5 |
| Current liabilities | 2636.6 | 1826.4 |
| Noncurrent liabilities | 3630.9 | 3987.8 |

---

At June 30, 2025 and December 31, 2024, the Obligor Group held current receivables due from other subsidiary companies of $28.6 million and $33.0 million, respectively; long-term notes receivable due from other subsidiary companies of $1.2 billion and $1.1 billion, respectively; and current payables due to other subsidiary companies of $13.5 million and $19.0 million, respectively.

---

| | |
|:---|:---|
| | Six Months Ended<br>June 30, 2025 |
| | (Dollars in millions) |
| Net sales | $1971.9 |
| Gross profit | 312.0 |
| Net income | 73.0 |

---

For the six months ended June 30, 2025, net income in the table above excludes income from equity method investments of other subsidiary companies of $83.9 million. For the six months ended June 30, 2025, the Obligor Group recorded the following transactions with other subsidiary companies: sales to such other subsidiary companies of $30.9 million; net credits from such other subsidiary companies of $12.0 million; and net interest income from such other subsidiary companies of $25.8 million. For the six months ended June 30, 2025, the Obligor Group did not receive dividends from other subsidiary companies.

***Rationalization Charges***

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Under our rationalization plans, we made cash payments of $8.0 million and $21.1 million for the six months ended June 30, 2025 and 2024, respectively. Excluding the impact of our withdrawal from the Central States Pension Plan in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $16.1 million and $21.6 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $0.8 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $2.6 million annually through 2040.

You should also read Note 3 to our Condensed Consolidated Financial Statements for the three and six months ended June 30, 2025 included elsewhere in this Quarterly Report.

------

Item 3. **<u>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</u>**

Market risks relating to our operations result primarily from changes in interest rates and, with respect to our international operations, in foreign currency exchange rates. In the normal course of business, we also have risk related to commodity price changes for items such as natural gas. We employ established policies and procedures to manage our exposure to these risks. Interest rate, foreign currency and commodity pricing transactions are used only to the extent considered necessary to meet our objectives. We do not utilize derivative financial instruments for trading or other speculative purposes.

Information regarding our interest rate risk, foreign currency exchange rate risk and commodity pricing risk has been disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Since such filing, other than the changes discussed in Notes 6 and 7 to our Condensed Consolidated Financial Statements for the three and six months ended June 30, 2025 included elsewhere in this Quarterly Report, there has not been a material change to our interest rate risk, foreign currency exchange rate risk or commodity pricing risk or to our policies and procedures to manage our exposure to these risks.

Item 4. **<u>CONTROLS AND PROCEDURES</u>**

As required by Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, we carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based upon that evaluation, as of the end of the period covered by this Quarterly Report, our Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms, and that our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including the Principal Executive Officer and the Principal Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal controls over financial reporting during the period covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, these internal controls.

In October 2024, we acquired Weener Packaging. We are currently in the process of integrating the internal controls and procedures of Weener Packaging into our internal controls over financial reporting. As provided under the Sarbanes-Oxley Act of 2002 and the applicable rules and regulations of the SEC, we will include the internal controls and procedures of Weener Packaging in our annual assessment of the effectiveness of our internal control over financial reporting for our 2025 fiscal year.

------

Part II. Other Information

Item 5. Other Information

In the second quarter of 2025, none of our directors or officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement" as defined in Item 408(c) of Regulation S-K.

Item 6. Exhibits

---

| | |
|:---|:---|
| <u>Exhibit Number</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Description</u> |
| 22 | <u>[Subsidiary Guarantors and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22 filed with our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025. Commission File No. 001-41459).](https://www.sec.gov/Archives/edgar/data/849869/000084986925000072/ex-22x2025331.htm)</u> |
| \*4.1 | <u>[Third Supplemental Indenture to the Indenture](exhibit41-6302025.htm)[dated as of February 10, 2021, with respect to the 1.4% Senior Secured Notes due 2026, by and among Silgan Holdings Inc.,](exhibit41-6302025.htm)[certain U.S. subsidiar](exhibit41-6302025.htm)[ies](exhibit41-6302025.htm)[of Silgan Holdings Inc. and Computershare Trust Company, N.A., as trustee and collateral agent.](exhibit41-6302025.htm)</u> |
| \*4.2 | <u>[Fifth Supplemental Indenture to the Indenture](exhibit42-6302025.htm)[dated as of November 12, 2019](exhibit42-6302025.htm)[,](exhibit42-6302025.htm)[with respect to the 4⅛% Senior Notes due 2028, by and among Silgan Holdings Inc.,](exhibit42-6302025.htm)[certain U.S. subsidiar](exhibit42-6302025.htm)[ies](exhibit42-6302025.htm)[of Silgan Holdings Inc. and U.S. Bank Trust Company, National Association, as trustee.](exhibit42-6302025.htm)</u> |
| \*31.1 | <u>[Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.](exhibit3116-30x2025.htm)</u> |
| \*31.2 | <u>[Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.](exhibit3126-30x2025.htm)</u> |
| \*32.1 | <u>[Certification by the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act.](exhibit3216-30x2025.htm)</u> |
| \*32.2 | <u>[Certification by the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act.](exhibit3226-30x2025.htm)</u> |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |

---

___________________

\*Filed herewith.

------

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| | SILGAN HOLDINGS INC. |
| Dated: August 7, 2025 | /s/ Kimberly I. Ulmer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; |
| | Kimberly I. Ulmer |
| | Senior Vice President and |
| | Chief Financial Officer |
| | (Principal Financial and |
| | Accounting Officer) |

---

## Exhibit 4.1

**Exhibit 4.1**

**Execution Version**

THIRD SUPPLEMENTAL INDENTURE

THIRD SUPPLEMENTAL INDENTURE (this "*Supplemental Indenture*"), dated as of March 18, 2025, among Silgan Specialty Packaging Triadelphia LLC (the "*Guaranteeing Subsidiary*"), a subsidiary of Silgan Holdings Inc. (or its permitted successor), a Delaware corporation (the "*Company*"), the Company, and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (the "*Trustee*") and collateral agent (the "*Collateral Agent*") under the Indenture referred to below.

W I T N E S S E T H

WHEREAS, the Company has heretofore executed and delivered to the Trustee and the Collateral Agent an indenture (the "*Base Indenture*"), dated as of February 10, 2021, providing for the issuance of $500,000,000 of its 1.400% Senior Secured Notes due 2026 (the "*Notes*"), a First Supplemental Indenture (the "*First Supplemental Indenture*"), dated as of November 5, 2021, providing for the unconditional guarantee of certain Subsidiary Guarantors of all of the Company's Obligations under the Notes and the Indenture, and a Second Supplemental Indenture (together with the Base Indenture and the First Supplemental Indenture, the "*Indenture*"), dated as of January 13, 2025, providing for the unconditional guarantee of a certain Subsidiary Guarantor of all of the Company's Obligations under the Notes and the Indenture;

WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally guarantee all of the Company's Obligations under the Notes and the Indenture on the terms and conditions set forth herein (each guarantee a "*Subsidiary Guarantee*"); and

WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee and the Collateral Agent are authorized to execute and deliver this Supplemental Indenture.

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiary and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. AGREEMENT TO GUARANTEE. The Guaranteeing Subsidiary hereby agrees to provide an unconditional Guarantee on the terms and subject to the conditions set forth in the Subsidiary Guarantee and in the Indenture, including but not limited to Article 10 thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. NO RECOURSE AGAINST OTHERS. No director, officer, employee, incorporator or stockholder of the Company or any Subsidiary Guarantor, as such, will have any liability for any obligations of the Company or any Subsidiary Guarantor under the Notes, the Indenture, the Subsidiary Guarantees or for any claim based on, in respect of, or by reason of, such obligations

------

or their creation. Each Holder of Notes by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. The waiver may not be effective to waive liabilities under the federal securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. NEW YORK LAW TO GOVERN. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE AND THE COLLATERAL AGENT. Neither the Trustee nor the Collateral Agent shall be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary and the Company.

*(remainder of page left blank; signature pages follow)*

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of the date first above written.

Dated: March 18, 2025,

---

| | |
|:---|:---|
| SILGAN SPECIALTY PACKAGING TRIADELPHIA LLC | SILGAN SPECIALTY PACKAGING TRIADELPHIA LLC |
| By: | /s/ Frank W. Hogan, III |
| Name: | Frank W. Hogan, III |
| Title: | Vice President and Secretary |
| SILGAN HOLDINGS INC. | SILGAN HOLDINGS INC. |
| By: | /s/ Frank W. Hogan, III |
| Name: | Frank W. Hogan, III |
| Title: | Executive Vice President, General Counsel and Secretary |

---

[Signature Page to Third Supplemental Indenture for 1.400% Senior Secured Notes due 2026]

------

---

| | |
|:---|:---|
| COMPUTERSHARE TRUST COMPANY, N.A., AS TRUSTEE AND COLLATERAL AGENT | COMPUTERSHARE TRUST COMPANY, N.A., AS TRUSTEE AND COLLATERAL AGENT |
| By: | /s/ Erika Mullen |
| Name: | Erika Mullen |
| Title: | Vice President |

---

[Signature Page to Third Supplemental Indenture for 1.400% Senior Secured Notes due 2026]

## Exhibit 4.2

**Exhibit 4.2**

**Execution Version**

FIFTH SUPPLEMENTAL INDENTURE

FIFTH SUPPLEMENTAL INDENTURE (this "*Supplemental Indenture*"), dated as of March 18, 2025, among Silgan Specialty Packaging Triadelphia LLC (the "*Guaranteeing Subsidiary*"), a subsidiary of Silgan Holdings Inc. (or its permitted successor), a Delaware corporation (the "*Company*"), the Company, the other Subsidiary Guarantors (as defined in the Indenture referred to herein), and U.S. Bank Trust Company, National Association (as successor-in-interest to U.S. Bank National Association), as trustee under the Indenture referred to below (the "*Trustee*").

W I T N E S S E T H

WHEREAS, the Company has heretofore executed and delivered to the Trustee an indenture dated as of November 12, 2019 (the "*Base Indenture*"), and a First Supplemental Indenture (the "*First Supplemental Indenture*"), dated as of February 26, 2020, providing for the issuance of $600,000,000 of its 4⅛% Senior Notes due 2028 (the "*Notes*"), a Second Supplemental Indenture (the "*Second Supplemental Indenture*"), dated as of February 10, 2021, providing for the unconditional guarantee of certain Subsidiary Guarantors of all of the Company's Obligations under the Notes and the Indenture (as defined below), a Third Supplemental Indenture (the "*Third Supplemental Indenture*"), dated as of November 5, 2021, providing for the unconditional guarantee of certain Subsidiary Guarantors of all of the Company's Obligations under the Notes and the Indenture, and a Fourth Supplemental Indenture (together with the Base Indenture, the First Supplemental Indenture, the Second Supplemental Indenture and the Third Supplemental Indenture, the "*Indenture*"), dated as of January 13, 2025, providing for the unconditional guarantee of a certain Subsidiary Guarantor of all of the Company's Obligations under the Notes and the Indenture;

WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally guarantee all of the Company's Obligations under the Notes and the Indenture on the terms and conditions set forth herein (each guarantee a "*Subsidiary Guarantee*"); and

WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiary and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT TO GUARANTEE. The Guaranteeing Subsidiary hereby agrees to provide an unconditional Guarantee on the terms and subject to the conditions set forth in the Subsidiary Guarantee and in the Indenture, including but not limited to Article 10 thereof.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NO RECOURSE AGAINST OTHERS. No director, officer, employee, incorporator or stockholder of the Company or any Subsidiary Guarantor, as such, will have any liability for any obligations of the Company or any Subsidiary Guarantor under the Notes, the Indenture, the Subsidiary Guarantees or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of Notes by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. The waiver may not be effective to waive liabilities under the federal securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NEW YORK LAW TO GOVERN. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which are made solely by the Guaranteeing Subsidiary and the Company. In acting hereunder, the Trustee shall have all of the rights, benefits, privileges, protections, immunities, and indemnities provided to the Trustee under the Indenture.

*(remainder of page left blank; signature pages follow)*

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

Dated: March 18, 2025,

---

| | |
|:---|:---|
| SILGAN SPECIALTY PACKAGING TRIADELPHIA LLC | SILGAN SPECIALTY PACKAGING TRIADELPHIA LLC |
| By: | /s/ Frank W. Hogan, III |
| Name: | Frank W. Hogan, III |
| Title: | Vice President and Secretary |
| SILGAN HOLDINGS INC. | SILGAN HOLDINGS INC. |
| By: | /s/ Frank W. Hogan, III |
| Name: | Frank W. Hogan, III |
| Title: | Executive Vice President, General Counsel and Secretary |
| SILGAN HOLDINGS LLC,<br>SILGAN CORPORATION | SILGAN HOLDINGS LLC,<br>SILGAN CORPORATION |
| By: | /s/ Frank W. Hogan, III |
| Name: | Frank W. Hogan, III |
| Title: | Executive Vice President, General Counsel and Secretary |

---

[Signature Page to Fifth Supplemental Indenture for 4⅛% Senior Notes due 2028]

------

---

| | |
|:---|:---|
| <br>SILGAN CONTAINERS LLC,<br>SILGAN PLASTICS LLC,<br>SILGAN WHITE CAP LLC,<br>SILGAN CONTAINERS MANUFACTURING CORPORATION,<br>SILGAN PLASTICS CORPORATION,<br>SILGAN TUBES HOLDING COMPANY,<br>SILGAN WHITE CAP CORPORATION,<br>SILGAN WHITE CAP AMERICAS LLC,<br>SILGAN EQUIPMENT COMPANY,<br>SILGAN IPEC CORPORATION,<br>SILGAN PLASTIC FOOD CONTAINERS CORPORATION,<br>PORTOLA PACKAGING LLC,<br>SILGAN DISPENSING SYSTEMS HOLDINGS COMPANY,<br>SILGAN DISPENSING SYSTEMS CORPORATION,<br>SILGAN DISPENSING SYSTEMS SLATERSVILLE LLC,<br>SILGAN DISPENSING SYSTEMS THOMASTON CORPORATION,<br>SILGAN DISPENSING SYSTEMS METAL HOLDINGS CORPORATION,<br>SILGAN DISPENSING SYSTEMS METAL REAL ESTATE CORPORATION,<br>SILGAN DISPENSING SYSTEMS COVIT AMERICA CORPORATION,<br>SILGAN SPECIALTY PACKAGING LLC,<br>SILGAN UNICEP PACKAGING LLC,<br>WEENER PLASTICS, INC. | <br>SILGAN CONTAINERS LLC,<br>SILGAN PLASTICS LLC,<br>SILGAN WHITE CAP LLC,<br>SILGAN CONTAINERS MANUFACTURING CORPORATION,<br>SILGAN PLASTICS CORPORATION,<br>SILGAN TUBES HOLDING COMPANY,<br>SILGAN WHITE CAP CORPORATION,<br>SILGAN WHITE CAP AMERICAS LLC,<br>SILGAN EQUIPMENT COMPANY,<br>SILGAN IPEC CORPORATION,<br>SILGAN PLASTIC FOOD CONTAINERS CORPORATION,<br>PORTOLA PACKAGING LLC,<br>SILGAN DISPENSING SYSTEMS HOLDINGS COMPANY,<br>SILGAN DISPENSING SYSTEMS CORPORATION,<br>SILGAN DISPENSING SYSTEMS SLATERSVILLE LLC,<br>SILGAN DISPENSING SYSTEMS THOMASTON CORPORATION,<br>SILGAN DISPENSING SYSTEMS METAL HOLDINGS CORPORATION,<br>SILGAN DISPENSING SYSTEMS METAL REAL ESTATE CORPORATION,<br>SILGAN DISPENSING SYSTEMS COVIT AMERICA CORPORATION,<br>SILGAN SPECIALTY PACKAGING LLC,<br>SILGAN UNICEP PACKAGING LLC,<br>WEENER PLASTICS, INC. |
| By: | /s/ Frank W. Hogan, III |
| Name: | Frank W. Hogan, III |
| Title: | Vice President and Secretary |

---

[Signature Page to Fifth Supplemental Indenture for 4⅛% Senior Notes due 2028]

------

---

| | |
|:---|:---|
| U.S. BANK TRUST COMPANY,<br>NATIONAL ASSOCIATION, as Trustee | U.S. BANK TRUST COMPANY,<br>NATIONAL ASSOCIATION, as Trustee |
| By: | /s/ Glen Fougere |
| Name: | Glen Fougere |
| Title: | Vice President |

---

[Signature Page to Fifth Supplemental Indenture for 4⅛% Senior Notes due 2028]

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT**

I, Adam J. Greenlee, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2025 of Silgan Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: August 7, 2025 | <u>/s/ Adam J. Greenlee</u> |
| | Adam J. Greenlee |
| | Chief Executive Officer and President |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION BY THE CHIEF FINANCIAL OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT**

I, Kimberly I. Ulmer, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2025 of Silgan Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: August 7, 2025 | <u>/s/ Kimberly I. Ulmer</u> |
| | Kimberly I. Ulmer |
| | Senior Vice President and |
| | Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT**

In connection with the Quarterly Report of Silgan Holdings Inc. (the "Company") on Form 10-Q for the period ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Quarterly Report"), I, Adam J. Greenlee, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

---

| |
|:---|
| (1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

---

---

| |
|:---|
| <u>/s/ Adam J. Greenlee</u> |
| Adam J. Greenlee |
| Chief Executive Officer and President |

---

August 7, 2025

A signed original of this written statement required by Section 906 has been provided to Silgan Holdings Inc. and will be retained by Silgan Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION BY THE CHIEF FINANCIAL OFFICER**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT**

In connection with the Quarterly Report of Silgan Holdings Inc. (the "Company") on Form 10-Q for the period ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Quarterly Report"), I, Kimberly I. Ulmer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

---

| |
|:---|
| (1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

---

---

| |
|:---|
| <u>/s/ Kimberly I. Ulmer</u> |
| Kimberly I. Ulmer |
| Senior Vice President and |
| Chief Financial Officer |

---

August 7, 2025

A signed original of this written statement required by Section 906 has been provided to Silgan Holdings Inc. and will be retained by Silgan Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

<br>